Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000152189 | SCV000200928 | uncertain significance | not specified | 2014-05-01 | criteria provided, single submitter | clinical testing | The Lys28325Glu variant in TTN has not been previously reported in individuals w ith cardiomyopathy, but has been identified in 1/3927 African American chromosom es by the NHLBI Exome Sequencing Project (http://evs.gs.washington.edu/EVS/). Co mputational prediction tools and conservation analysis do not provide strong sup port for or against an impact to the protein. In summary, the clinical significa nce of the Lys28325Glu variant is uncertain. |
Labcorp Genetics |
RCV000533851 | SCV000643904 | uncertain significance | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2017-05-31 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001559358 | SCV001781572 | likely benign | not provided | 2020-11-10 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 28611029) |
Ambry Genetics | RCV002362798 | SCV002660211 | likely benign | Cardiovascular phenotype | 2020-03-31 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Revvity Omics, |
RCV001559358 | SCV003824201 | uncertain significance | not provided | 2020-10-24 | criteria provided, single submitter | clinical testing |